← Search & browse all drugs
ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › SULFONAMIDES AND TRIMETHOPRIM › Short-acting sulfonamides
combinations
J01EB20
Forms & Strengths
- Various fixed-dose combinations of antibacterials (ATC J01EB20)
- Oral tablets and capsules containing specific synergistic antimicrobial ratios
Adult Dosing
- Dosage highly variable depending on the specific combination product constituents
- Typically administered orally twice to four times daily according to specific agent guidelines
- Duration of therapy depends on the specific infection type and clinical response
Pediatric Dosing
- Dosing determined by the specific active ingredients and pediatric weight-based guidelines
- Consult specific product labeling for age and weight restrictions
Indications
- Treatment of susceptible bacterial infections as determined by specific combination formulation
- Urinary tract infections and other targeted bacterial pathologies
Mechanism of Action
- Combined antibacterial action via inhibition of bacterial cell wall synthesis, protein synthesis, or nucleic acid replication depending on constituent agents
- Synergistic bactericidal or bacteriostatic effects against susceptible pathogens
Contraindications
- Hypersensitivity to any of the active ingredients or component classes
- Specific contraindications vary by the exact constituent drugs in the combination
Adverse Reactions
- Gastrointestinal disturbances including nausea, vomiting, and diarrhea
- Hypersensitivity reactions ranging from rash to anaphylaxis
- Superinfections with prolonged use
Drug Interactions
- Potential for additive toxicity or altered clearance depending on constituent agents
- Interactions with CYP450 enzyme inducers or inhibitors specific to the component drugs
Curated Content: Needs Vetting Before Put to Clinical Use